Get the Stockscreener App
2.345
0.21%
0.005
Bone Biologics Corp stock is traded at $2.345, with a volume of 16,193.
It is up +0.21% in the last 24 hours and down -20.24% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$2.34
Open:
$2.34
24h Volume:
16,193
Relative Volume:
0.03
Market Cap:
$1.28M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.3234
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
-11.17%
1M Performance:
-20.24%
6M Performance:
-62.06%
1Y Performance:
-74.29%
1-Day Range:
$2.2965
$2.39
1-Week Range:
$2.255
$2.73
52-Week Range:
$2.255
$16.50
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
2.345 | 3.76M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Bone Biologics Corp Stock (BBLG) Latest News
What does recent volatility data suggest for Bone Biologics Corporation2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Using data models to predict Bone Biologics Corporation stock movement2025 Historical Comparison & Momentum Based Trading Signals - Newser
Trend analysis for Bone Biologics Corporation this week2025 Top Decliners & Reliable Price Breakout Alerts - Newser
Will Bone Biologics Corporation Equity Warrant price bounce be sustainableJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Does Bone Biologics Corporation Equity Warrant qualify in momentum factor screeningJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
What makes Bone Biologics Corporation stock price move sharplyJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - Newser
Published on: 2025-08-13 00:20:14 - Newser
Detecting price anomalies in Bone Biologics Corporation with AIFree Low Risk Picks for Daily Trading - Newser
Price momentum metrics for Bone Biologics Corporation explainedPredictable Return Strategy with AI Support - Newser
Statistical indicators supporting AppTech Payments Corp.’s strengthTrade Setup Builder with Custom Alerts - Newser
Evaluating Critical Metals Corp. Equity Warrant with trendline analysisFree Risk-Adjusted Picks With Exit Strategy - Newser
Applying sector rotation models to Bone Biologics CorporationFree Trade Insight With Community Collaboration - Newser
What to expect from Bone Biologics Corporation Equity Warrant in the next 30 daysFree Fundamental Growth Stock Analysis - Newser
Visualizing Bone Biologics Corporation Equity Warrant stock with heatmapsRisk-Managed Swing Setup and Signal Analysis - Newser
How hedge fund analytics apply to Bone Biologics Corporation Equity Warrant stockBuy Zone Strategy with Pattern Recognition - Newser
How institutional ownership impacts Bone Biologics Corporation stockEarly Entry Ideas with Momentum Potential - Newser
Will a bounce in First National Corporation offer an exitTriple Digit Gain Opportunity Watchlist - Newser
Using data filters to optimize entry into SANUWAVE Health Inc.Short-Term Bounce Forecast for Oversold Stocks - Newser
Will Eureka Acquisition Corp Equity Right benefit from macro trendsFree AI Screening for Swing Trade Picks - Newser
Published on: 2025-08-10 05:07:15 - Newser
Can technical indicators confirm Bone Biologics Corporation Equity Warrant’s reversalSwing Candidate List with Trade Cues - Newser
Pure Cycle Corporation stock chart pattern explainedShort-Term Trade Setup with Forecast Insight - Newser
Real time breakdown of Bone Biologics Corporation Equity Warrant stock performance - Newser
How to forecast Bone Biologics Corporation trends using time seriesHigh Return Idea With Technical Filter - Newser
Bone Biologics Corporation stock prediction for this weekStock Market Trend and Pattern Analysis - Newser
Price momentum metrics for Bone Biologics Corporation Equity Warrant explainedGrowth Projection Summary for Long-Term Investors - Newser
Using fundamentals and technicals on Amazon.com Inc.Strong Buy Signal Summary with Entry Zone - Newser
What earnings revisions data tells us about Bone Biologics CorporationSummary of Long-Term Buy Zone Stocks - Newser
Heatmap analysis for Centurion Acquisition Corp. Debt Equity Composite Units and competitorsBuy Candidate Summary Based on Fundamentals - Newser
Pheton Holdings Ltd stock volume spike explainedAsset Allocation Summary With Future Outlook - Newser
Can momentum traders help lift Central Pacific Financial Corp.Stable Profit Zone and Loss Control Analysis - Newser
Why Horizon Space Acquisition II Corp. stock attracts strong analyst attentionStock Trading Session Highlights and Summary - Newser
Is B2Gold Corp. still worth holding after the dipFree Risk Controlled Short Term Trade Plans - Newser
Why Embrace Change Acquisition Corp. Equity Warrant stock is on top investor watchlistsEarnings Report Summary with Market Impact - Newser
Intrinsic Value of UGRO Stock: Is It Undervalued or OvervaluedDaily Exit and Entry Price Prediction - Newser
Alzamend Neuro Inc. stock momentum explainedFree Conservative Long Term Growth Plans - Newser
Using Bollinger Bands to evaluate Bone Biologics Corporation Equity WarrantQuick Profit Setup with Signal Forecast - Newser
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):